new glp-1 drug retatrutide obesity drug, retatrutide, shows added benefits Understanding the Next-Gen Weight Loss

Gut T cells feast on GLP-1 to modulate cardiometabolic disease

This article was previously distributed in the August 22, 2023, educational email of the Patient Safety Authority, available at About the Author Patient Safety Authority (patientsafety.pa.gov) is an independent state agency that oversees the Pennsylvania Patient Safety Reporting System (PA-PSRS), the largest database of its kind in the United States.

For those considering medically supervised weight loss, Rivas Medical Weight Loss offers comprehensive plans and expert care to support your health journey

However, Retatrutide is not commercially available or FDA-approved yet

GLP-1 and underlying beneficial actions in Alzheimers disease, hypertension, and NASH